World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
66
Citations
15826
World Ranking
2396
National Ranking
207

Marc Lipman publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Marc Lipman sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 288 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Marc Lipman D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Marc Lipman sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 66 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Marc Lipman is affiliated with the Royal Free London NHS Foundation Trust in the United Kingdom. Their research primarily focuses on infectious diseases, with significant contributions to tuberculosis (TB) research and epidemiology, pneumocystis jirovecii pneumonia detection and treatment, and COVID-19 clinical research studies.

The scientist has published extensively in the field of medicine, with 269 works attributed to this broad domain. Within this, they have concentrated on subfields including infectious diseases, epidemiology, surgery, pulmonary and respiratory medicine, and neurology. Their work covers critical topics such as tuberculosis research and epidemiology, Mycobacterium research and diagnosis, pneumonia and respiratory infections, HIV/AIDS research and interventions, and the diagnosis and treatment of tuberculosis.

Marc Lipman's recent published papers include:

  • 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 (2020, Thorax)
  • Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes (2020, Annals of Clinical Microbiology and Antimicrobials)
  • Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study (2021, The Lancet Respiratory Medicine)
  • Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study (2020, European Respiratory Journal)
  • Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis (2020, The Lancet Respiratory Medicine)

The frequent coauthors collaborating with Marc Lipman include Ibrahim Abubakar, Heinke Kunst, James Brown, John R. Hurst, and Robert F. Miller. This network reflects active engagement with other researchers in overlapping areas of infectious diseases and respiratory medicine.

Marc Lipman has frequently published in notable venues such as bioRxiv (Cold Spring Harbor Laboratory), The Lancet Respiratory Medicine, European Respiratory Journal, ERJ Open Research, and AIDS. These platforms have supported dissemination of their work in both respiratory and infectious disease research communities.

Best Publications

  • Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials

    Punam Mangtani;Ibrahim Abubakar;Cono Ariti;Rebecca Beynon

  • Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

    Martina Sester;Giovanni Sotgiu;Christoph Lange;Claudia Giehl

  • Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

    Rachael A Evans;Hamish McAuley;Ewen M Harrison;Aarti Shikotra

  • Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

    R A M Breen;C J Smith;H Bettinson;S Dart

  • Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis

    I Abubakar;L Pimpin;C Ariti;R Beynon

  • Drug-resistant tuberculosis: time for visionary political leadership

    Ibrahim Abubakar;Ibrahim Abubakar;Matteo Zignol;Dennis Falzon;Mario Raviglione

  • Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

    Chloe I. Bloom;Christine M. Graham;Matthew P. R. Berry;Matthew P. R. Berry;Fotini Rozakeas

  • MMP-1 drives immunopathology in human tuberculosis and transgenic mice

    Paul Elkington;Takayuki Shiomi;Ronan Breen;Robert K. Nuttall

  • Outcome of HIV-Associated Tuberculosis in the Era of Highly Active Antiretroviral Therapy

    Keertan Dheda;Fiona C. Lampe;Margaret A. Johnson;Marc C. Lipman

  • Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral Therapy

    Stephen D. Lawn;Robert J. Wilkinson;Marc C. I. Lipman;Robin Wood

  • RE: “ESTIMATED RATE OF REACTIVATION OF LATENT TUBERCULOSIS INFECTION IN THE UNITED STATES, OVERALL AND BY POPULATION SUBGROUP”

    R. M. G. J. Houben;T. A. Yates;D. A. J. Moore;T. D. McHugh

  • Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.

    Toyin Togun;Beate Kampmann;Neil Graham Stoker;Marc Lipman;Marc Lipman

  • Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection

    R A M Breen;R F Miller;T Gorsuch;C J Smith

  • Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial

    Alistair Story;Alistair Story;Robert W Aldridge;Catherine M Smith;Elizabeth Garber;Elizabeth Garber

  • The transmission of Mycobacterium tuberculosis in high burden settings

    Tom A Yates;Tom A Yates;Palwasha Y Khan;Gwenan M Knight;Gwenan M Knight;Jonathon G Taylor

  • Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy

    Chloe I. Bloom;Christine M. Graham;Matthew P. R. Berry;Matthew P. R. Berry;Katalin A. Wilkinson;Katalin A. Wilkinson

  • Treatment of Latent Tuberculosis Infection: A Network Meta-analysis

    Helen R. Stagg;Dominik Zenner;Ross J. Harris;Laura Muñoz

  • Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients

    M Bofill;A Mocroft;M Lipman;E Medina

  • Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis

    Dominik Zenner;Netta Beer;Ross J Harris;Marc Ci Lipman;Marc Ci Lipman

  • Immune reconstitution inflammatory syndrome in HIV.

    Marc Lipman;Ronan Breen

  • Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study

    Abubakar I;Drobniewski F;Southern J;Sitch Aj

  • First evaluation of QuantiFERON-TB gold plus performance in contact screening

    Lucia Barcellini;Emanuele Borroni;James Brown;Enrico Brunetti

  • Tuberculosis and HIV co-infection: a practical therapeutic approach.

    Ronan A. M. Breen;Leonie Swaden;Jayne Ballinger;Marc C. I. Lipman

Frequent Co-Authors

Ibrahim Abubakar
Ibrahim Abubakar University College London
Timothy D. McHugh
Timothy D. McHugh University College London
Margaret Johnson
Margaret Johnson The Royal Free Hospital
Robert J. Wilkinson
Robert J. Wilkinson The Francis Crick Institute
Francis Drobniewski
Francis Drobniewski Imperial College London
Anne O'Garra
Anne O'Garra The Francis Crick Institute
Mahdad Noursadeghi
Mahdad Noursadeghi University College London
George Janossy
George Janossy University of the Witwatersrand
Stephen H. Gillespie
Stephen H. Gillespie University of St Andrews
Damien Chaussabel
Damien Chaussabel Sidra Medical and Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology opens diverse career opportunities in healthcare, research, and administration. For example, becoming a child life specialist requires specialized knowledge and offers a fulfilling path focused on supporting children and families during medical treatments. Understanding functional medicine nurse practitioner roles also complements microbiology studies by applying integrative healthcare practices that consider the microbiome’s impact on overall wellness.

Online degrees can be particularly valuable for those seeking flexible education options, including degrees felons can get. These programs help break barriers and provide access to meaningful careers with licensure or certification paths. For instance, training to become a certified professional coder (CPC) offers a technical, in-demand role in healthcare billing and coding, which is crucial for clinical documentation and reimbursement.

Choosing the right online degree aligned with your career goals in microbiology can open doors to specialized healthcare roles, lab research, or administrative positions, all benefiting from a foundational understanding of microbial science.

Best Scientists Citing Marc Lipman

Trending Scientists

Recently Published Articles